MLH1 and cancer: The MMR system is frequently deregulated in cancer (MMR deficiency—dMMR), through the mutation of one of its genes (more commonly MSH2, MSH6, MLH1 and PMS2) or by the hypermethylation-induced silencing of the MLH1 gene [94].